The trajectory of companies tied to Sildenafil's legacy presents a intricate investment picture . While the initial surge generated substantial gains, generic competition have significantly diminished https://tbookmark.com/story21490991/copyright-s-flagship-product-and-big-pharma-a-speculative-venture